SCHEMBL1551334

SCHEMBL1551334

COC(=O)Cc1cc(C)cs1

nearest known ligand 0.43

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
HSP90AB1 P08238 1/20 0.43
DAO P14920 1/20 0.41
KDM4C Q9H3R0 1/20 0.40
GAA P10253 3/20 0.38
KDM4E B2RXH2 3/20 0.38
HSD17B10 Q99714 3/20 0.38
CASP1 P29466 1/20 0.38
CASP7 P55210 1/20 0.38
NPSR1 Q6W5P4 1/20 0.38
RXFP1 Q9HBX9 1/20 0.38
PDE10A Q9Y233 2/20 0.38
RPS6KB2 Q9UBS0 1/20 0.38
CYP4F2 P78329 1/20 0.37
CYP4A11 Q02928 1/20 0.37
ALDH1A1 P00352 5/20 0.37
GFER P55789 1/20 0.37
MEN1 O00255 1/20 0.36
MAPT P10636 1/20 0.36
KMT2A Q03164 1/20 0.36
SMN1; SMN2 Q16637 1/20 0.36

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL6976089 0.84 SMN1; SMN2 (0.47) DAOGAAALDH1A1MEN1KMT2A
SCHEMBL3939509 0.82 RPS6KB2 (0.42) DAOKDM4CHSD17B10PDE10ARPS6KB2
SCHEMBL8139675 0.81 HSP90AB1 (0.52) HSP90AB1DAOGAAKDM4EHSD17B10
SCHEMBL2332944 0.81 HSP90AB1 (0.43) HSP90AB1GAAHSD17B10CASP1CASP7
SCHEMBL27942177 0.80 DAO (0.47) DAOKDM4CKDM4ENPSR1PDE10A
Hydrochloric Acid SCHEMBL27660641 0.80 HSP90AB1 (0.42) HSP90AB1GAAHSD17B10CASP1CASP7
SCHEMBL27351557 0.80 HSP90AB1 (0.50) HSP90AB1DAOGAAKDM4EHSD17B10
SCHEMBL27660644 0.80 HSP90AB1 (0.42) HSP90AB1DAOGAAKDM4EHSD17B10
SCHEMBL2332640 0.79 PARP1 (0.45) HSP90AB1DAOGAAKDM4EHSD17B10
SCHEMBL13185510 0.79 GSK3B (0.44) HSP90AB1DAOGAAHSD17B10RPS6KB2

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 6 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-8492411-B2 5-(4-methanesulfonyl-phenyl)-thiazole derivatives for the treatment of acute and chronic inflammatory diseases FAES FARMA, S.A. (ES) 2013-07-23 US disclosed
EP-2313382-A1 5-(4-METHANESULFONYL-PHENYL)-THIAZOLE DERIVATIVES FOR THE TREATMENT OF ACUTE AND CHRONIC INFLAMMATORY DISEASES FAES FARMA, S.A. (ES) 2011-04-27 EP disclosed
US-20100305164-A1 5-(4-METHANESULFONYL-PHENYL)-THIAZOLE DERIVATIVES FOR THE TREATMENT OF ACUTE AND CHRONIC INFLAMMATORY DISEASES FAES FARMA, S.A. (ES) 2010-12-02 US disclosed
US-7781594-B2 5-(4-methanesulfonyl-phenyl)-thiazole derivatives for the treatment of acute and chronic inflammatory diseases FAES FARMA, S.A. (ES) 2010-08-24 US disclosed
WO-2009153226-A1 5-(4-METHANESULFONYL-PHENYL)-THIAZOLE DERIVATIVES FOR THE TREATMENT OF ACUTE AND CHRONIC INFLAMMATORY DISEASES FAES FARMA, S.A. (ES) 2009-12-23 WO disclosed
US-20090312376-A1 5-(4-METHANESULFONYL-PHENYL)-THIAZOLE DERIVATIVES FOR THE TREATMENT OF ACUTE AND CHRONIC INFLAMMATORY DISEASES FAES FARMA, S.A. (ES) 2009-12-17 US disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (2 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20090312376-A1 5-(4-METHANESULFONYL-PHENYL)-THIAZOLE DERIVATIVES FOR THE TREATMENT OF ACUTE AND CHRONIC INFLAMMATORY DISEASES IL6, CXCL8, IL1B HSP90AB1 1760/4885DAO 2269/4885KDM4C 3436/4885
US-20100305164-A1 5-(4-METHANESULFONYL-PHENYL)-THIAZOLE DERIVATIVES FOR THE TREATMENT OF ACUTE AND CHRONIC INFLAMMATORY DISEASES IL6, CXCL8, IL1B HSP90AB1 1339/4885DAO 2323/4885KDM4C 3968/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.